Package 69097-431-05

Brand: darifenacin

Generic: darifenacin hydrobromide
NDC Package

Package Facts

Identity

Package NDC 69097-431-05
Digits Only 6909743105
Product NDC 69097-431
Product ID 69097-431_99ca2704-b757-4f10-be5c-bd01dff69b10
Description

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-05)

Marketing

Marketing Status
Marketed Since 2016-09-01
Brand darifenacin
Generic darifenacin hydrobromide
Sample Package No

Linked Drug Pages (1)

Darifenacin ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "99ca2704-b757-4f10-be5c-bd01dff69b10", "openfda": {"unii": ["CR02EYQ8GV"], "rxcui": ["485421", "485423"], "spl_set_id": ["6e8470d1-c3e6-4644-b70a-aa47ddf79676"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-02)", "package_ndc": "69097-431-02", "marketing_start_date": "20160901"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-05)", "package_ndc": "69097-431-05", "marketing_start_date": "20160901"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-15)", "package_ndc": "69097-431-15", "marketing_start_date": "20160901"}], "brand_name": "Darifenacin", "product_id": "69097-431_99ca2704-b757-4f10-be5c-bd01dff69b10", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "69097-431", "generic_name": "Darifenacin Hydrobromide", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Darifenacin", "active_ingredients": [{"name": "DARIFENACIN HYDROBROMIDE", "strength": "7.5 mg/1"}], "application_number": "ANDA207664", "marketing_category": "ANDA", "marketing_start_date": "20160901", "listing_expiration_date": "20261231"}